Eurolife Healthcare announced to invest INR 100 crores for expanding its production capacity of closed intravenous infusion bottle.
The company has reported to have recently signed a pact with a Chinese firm in manufacturing infusion bottles with high-speed machinery using the latest technology.
With the investment, Eurolife plans to start the contract for production by the 1st Quarter of 2020. The increased production capacity will enable the manufacture of an additional 40 million of the close system IV bottles monthly, said Mr. Sandeep Toshniwal CEO, Eurolife Healthcare in a news release.
The new investment in technology and manufacture will enhance the company’s existing production capacity from 20 million to more than 60 million IV infusion bottles a month, said the company.